Clinical Trials Directory

Trials / Completed

CompletedNCT03285750

Expression of G-protein Coupled Receptor 120 Receptor in Adipose Tissue of German Diabetes Center Cohort Subjects

Expression of GPR120 Receptor in Adipose Tissue of Type 2 Diabetic Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
German Diabetes Center · Academic / Other
Sex
All
Age
20 Years – 69 Years
Healthy volunteers
Accepted

Summary

G-protein coupled receptor 120 (GPR120) is a G-protein-coupled receptor whose endogenous ligands have been identified as long-chain fatty acids. Recently, it has been shown that GPR120 expression in human adipose tissue is higher in obese than in lean individuals. Interestingly, a GPR120 deficient mouse model presents an unfavorable phenotype when fed a high-fat diet with obesity, glucose intolerance and fatty liver, characteristics also found in type 2 diabetes (T2D). Moreover, in obese subjects, a single nucleotide polymorphism (R270H) has been identified that inhibits GPR120 signaling activity. The investigators now want to investigate if GPR120 expression in adipose tissue may be altered in patients with T2D compared to non-diabetic subjects and might contribute to diabetes-associated metabolic changes. Additionally, the investigators want to assess the frequency of the R270H mutant in T2D.

Conditions

Timeline

Start date
2013-08-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2017-09-18
Last updated
2023-06-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03285750. Inclusion in this directory is not an endorsement.